Atif Zafar

机构：Cleveland Clinic · ORCID：0000-0002-2738-5225

发表论文 151 篇 · 总被引 3448 次 · h-index 25

代表论文

• Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial (2022 · The Lancet · 被引 478)
• Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion (2025 · New England Journal of Medicine · 被引 270)
• Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial (2024 · The Lancet · 被引 141)
• Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke (2023 · JAMA Neurology · 被引 69)
• Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial (2025 · The Lancet · 被引 63)
• Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial (2023 · Stroke · 被引 40)